One of the greatest challenges that we face in discovering new disease therapies is that most proteins are considered “undruggable.” Our research group is reimagining druggability by using chemoproteomic approaches to tackle the undruggable proteome.
Meet Our Team
We are a group of highly motivated scientists with a desire to engage in multidisciplinary research at the interface of chemistry and biology.
Latest NewsVIEW ALL NEWS
Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease
Novartis and UC Berkeley Extend Alliance to Tackle “Undruggable” Disease Targets and Discover New Therapeutic Modalities
Follow us on Twitter @DanNomura